granulomatosis with polyangiitis

GPTKB entity

Statements (56)
Predicate Object
gptkbp:instance_of gptkb:healthcare_organization
gptkbp:bfsLayer 4
gptkbp:bfsParent gptkb:Rituxan
gptkbp:affects gptkb:skincare_product
kidneys
lungs
joints
blood vessels
eyes
upper respiratory tract
gptkbp:associated_with ANCA antibodies
gptkbp:caused_by gptkb:musician
inflammation
gptkbp:complications hearing loss
lung damage
skin lesions
nerve damage
kidney failure
gptkbp:contains_allergens gptkb:theorem
gptkbp:current_use gptkb:microscopic_polyangiitis
gptkb:Churg-Strauss_syndrome
gptkb:Wegener's_granulomatosis
gptkbp:first_described_by 1950s
gptkbp:gender more common in males
https://www.w3.org/2000/01/rdf-schema#label granulomatosis with polyangiitis
gptkbp:is_monitored_by regular follow-ups
lung function tests
kidney function tests
ANCA levels
gptkbp:is_popular_in rare
gptkbp:named_after gptkb:Friedrich_Wegener
gptkbp:premiered_on adulthood
gptkbp:research ongoing
gptkbp:risk_factor smoking
genetic predisposition
infections
environmental exposures
gptkbp:scientific_classification small vessel vasculitis
gptkbp:social_responsibility CT scan
variable
blood tests
biopsy
depends on severity
depends on treatment
gptkbp:symptoms fatigue
cough
sinusitis
hematuria
gptkbp:treatment gptkb:methotrexate
gptkb:theorem
gptkb:cyclophosphamide
gptkb:rituximab
gptkb:azathioprine
corticosteroids
plasma exchange
immunosuppressants